Sandoz 663 Sandoz 663 (Cefdinir 300 mg)
Pill imprint Sandoz 663 Sandoz 663 has been identified as Cefdinir 300 mg.
Cefdinir is used in the treatment of sinusitis; otitis media; skin or soft tissue infection; skin and structure infection; pneumonia (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefdinir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Sandoz 663 Sandoz 663
- 300 mg
- 22.00 mm
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- carboxymethylcellulose calcium
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|67253-0011||DAVA Pharmaceuticals, Inc.|
Note: Inactive ingredients may vary.
More about cefdinir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.